On Jan 7, 2025 (Sweden), Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression. The details This is a big step for cell-based therapies for potentially curing T1D. Sana’s first-in-human study consists of allogeneic islets, meaning […]
2024 was certainly a year of transformation. We recognized 50 years of grassroots fundraising and advocacy in Canada and in November we became Breakthrough T1D™ Canada. And while we now have a new name and look, our mission remains the same. We are as steadfast as ever about reaching our ultimate goal, a world free […]
Breakthrough T1D provides seed funding for highly innovative research with significant potential to accelerate the most promising type 1 diabetes (T1D) research in both cures and approaches to improve disease management. Breakthrough T1D Innovation Grants address key challenges in T1D research and have the potential to generate ground-breaking discoveries. These grants support a wide range […]
Hannah was born on August 4, 1994, in Ottawa, Ontario, Canada. She began skiing at 2 and joined the Mont-Tremblant Ski Club at 12, where she developed a passion for ski racing. Hannah’s talent quickly propelled her to the top ranks in alpine skiing, achieving multiple podiums in FIS-sanctioned events. Hannah’s World Cup career began […]
The holiday season is fast approaching, and with it the stress of finding that perfect gift for the important people in your life. Why not let Breakthrough T1D give you some ideas to help you really spoil your loved one living with type 1 diabetes (T1D). We’ve put together a gift guide with some fun […]
Winter is on its way, and with it the holiday season and the parties and meals that come along with it. Most of us find we indulge a little more in holiday snacks and treats – and these are often sugar and carb laden. One of the major stresses of managing type 1 diabetes (T1D), […]
Canada is home to world-class researchers who are making discoveries with the potential to improve the lives of people living with type 1 diabetes (T1D). However, these research findings can only make a difference if we share them with the knowledge users, ie. the right people, including health care providers, people living with T1D and […]
On October 28, 2024, the Breakthrough T1D Centre of Excellence at the University of British Columbia (UBC) held its third annual meeting on UBC campus in Vancouver to discuss progress to date as well as the team’s ambitious plans for Years 4 and 5 of the research program. During Year 3, the team made several […]
Breakthrough T1D’s largest advocacy event – Kids For a Cure was held from November 3rd to 5th in Ottawa, Ontario. Held every two years, Kids for a Cure is Breakthrough T1D Canada’s most important advocacy initiative. Our youth advocates from across Canada help politicians understand the daily challenges of living with type 1 diabetes (T1D) […]
Dr. Alyssa Weinrauch is the third annual recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes (T1D), jointly funded by Breakthrough T1D Canada and the Stem Cell Network (SCN) based at the Breakthrough T1D Centre of Excellence at the University of British Columbia (UBC). The J. Andrew McKee Fellowship in Type 1 Diabetes, […]
Since 1986, corporate Canada has been participating in one of Canada’s longest running and top fundraising events, the JDRF Ride to Defeat Diabetes. This year rides were held in Montréal and Toronto on October 10 and 16 and 17, respectively, along with ‘Ride Your Way’ events taking place across the country all October. T1D is […]
From September 9-13th, 2024, scientists, healthcare professionals, and the diabetes community from around the world gathered in Madrid, Spain for the European Association for the Study of Diabetes (EASD) annual conference. The event was attended by researchers, clinicians, pharmaceutical and device companies, regulators and leaders in the diabetes field from more than 120 countries, and […]
